- Home
- CRVS vs BRAI Comparison
CRVS vs BRAI Comparison
Compare CRVS & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.09
Company Overview
Basic Information| Metric | CRVS | BRAI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVS | BRAI |
|---|---|---|
| Price | $14.09 | $25.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $28.20 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 77.4K |
| Earning Date | 03-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.54 | $12.56 |
| 52 Week High | $26.95 | $32.32 |
Technical Indicators
Market Signals| Indicator | CRVS | BRAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 50.37 |
| Support Level | $6.65 | $18.60 |
| Resistance Level | $18.73 | $25.00 |
| Average True Range (ATR) | 0.95 | 4.48 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 27.18 | 40.72 |
Price Performance
Historical Comparison CRVS
BRAI
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).